PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) from its SEC filings: 2025 revenue $160.0 million (+4% vs the year before), net margin -342%, free cash flow -$113.9 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Laboratory Analytical Instruments |
| Revenue (2025) | $160.0 million |
| Revenue growth | +4% |
| Net income | -$546.4 million |
| Net margin | -341.5% |
| Free cash flow | -$113.9 million |
| Diluted EPS | $-1.82 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | -2% |
| Cash | $61.0 million |
| Long-term debt | $13.3 million |
| Share count, 1 year | +4% |
| Fundamentals check | Weak fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.